Base editor treats progeria in mice

Nature

  • RESEARCH SUMMARY

Base editor treats progeria in mice

Access options

doi: https://doi.org/10.1038/d41586-021-01114-8

References

  1. 1.

    Eriksson, M. et al. Nature 423, 293–298 (2003).

    PubMed 
    Article 

    Google Scholar
     

  2. 2.

    De Sandre-Giovannoli, A. et al. Science 300, 2055 (2003).

    PubMed 
    Article 

    Google Scholar
     

  3. 3.

    Gordon, L. B., Brown, W. T. & Collins, F. S. Hutchinson–Gilford Progeria Syndrome (GeneReviews, 2019).


    Google Scholar
     

  4. 4.

    Gordon, L. B. et al. Proc. Natl Acad. Sci. USA 109, 16666–16671 (2012).

    PubMed 
    Article 

    Google Scholar
     

  5. 5.

    Gaudelli, N. M. et al. Nature 551, 464–471 (2017).

    PubMed 
    Article 

    Google Scholar
     

  6. 6.

    Anzalone, A. V., Koblan, L. W. & Liu, D. R. Nature Biotechnol. 38, 824–844 (2020).

    PubMed 
    Article 

    Google Scholar
     

  7. 7.

    Grimm, D. & Zolotukhin, S. Mol. Ther. 23, 1819–1831 (2015).

    PubMed 
    Article 

    Google Scholar
     

Download references

Competing Interests

D.R.L. is a co-founder of Beam Therapeutics, Prime Medicine, Pairwise Plants and Editas Medicine, companies that use genome editing.

Subjects

Nature Briefing

An essential round-up of science news, opinion and analysis, delivered to your inbox every weekday.





Articles You May Like

Net zero’s big challenge for small business
Tesla restarts Model S deliveries after a strange weeklong hold
Quick Charge Podcast: July 29, 2021
Scientists — reach across the aisle, Republicans could be back soon
There could be a new explanation of underground ‘lakes’ on Mars, but it’s not water

Leave a Reply

Your email address will not be published. Required fields are marked *